Colorectal Cancer Stage Distribution at First and Repeat Fecal Immunochemical Test Screening
Authors:
Open Access
- 22 August 2023
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 21 (13) , 3424-3432.e2
Abstract
No abstract availableKeywords
Funding Information
- Fujifilm Corporation
- Rijksinstituut voor Volksgezondheid en Milieu
- Medtronic
This publication has 19 references indexed in Scilit:
- Impact of a higher fecal immunochemistry test cut-off on pathology detected in subsequent rounds of a colorectal screening programGastrointestinal Endoscopy, 2019
- Stage distribution of screen-detected colorectal cancers in the NetherlandsGut, 2017
- Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off LevelsGastroenterology, 2017
- Shift to earlier stage at diagnosis as a consequence of the National Bowel Cancer Screening ProgramMedical Journal of Australia, 2013
- Colorectal-Cancer Incidence and Mortality with Screening Flexible SigmoidoscopyNew England Journal of Medicine, 2012
- Higher Fecal Immunochemical Test Cutoff Levels: Lower Positivity Rates but Still Acceptable Detection Rates for Early-Stage Colorectal CancersCancer Epidemiology, Biomarkers & Prevention, 2011
- A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening roundsGut, 2002
- What's the Relative Risk?JAMA, 1998
- Randomised controlled trial of faecal-occult-blood screening for colorectal cancerThe Lancet, 1996
- Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult BloodNew England Journal of Medicine, 1993